InvestorsHub Logo

pennystock_es

10/25/20 4:19 AM

#462 RE: midastouch017 #461

Dr. Babecoff continued, "We have developed expertise and IP in pursuit of our goals, and we retain a state-of-the-art manufacturing facility. Going forward, we will examine options to maximize the value of these assets." $BVXV

https://www.prnewswire.com/news-releases/biondvax-announces-topline-results-from-phase-3-clinical-trial-of-the-m-001-universal-influenza-vaccine-candidate-301158876.html

Spideyboy

10/26/20 9:53 AM

#468 RE: midastouch017 #461

Seems my discomfort on the lack of clear data was warranted.

Sorry about this though and if it had worked would have been quite fantastic for untold millions of people.